Molecular targeted therapy for systemic lupus erythematosus

Key Points

• This research aims to explore molecular targeted therapies for treating systemic lupus erythematosus.
• Focused on the role of b lymphocyte stimulator (BlyS) and TNF.
• Examined interactions involving b cell activating factor (BAFF).
• Identified potential therapeutic targets that may enhance treatment options.
• Highlighted the relevance of BlyS and BAFF in managing systemic lupus erythematosus.